Plasma concentrations at seven days of medication revealed therapeutic levels of parecoxib, valdecoxib, and diclofenac. Nanotechnology devices are being developed for diagnosis of cancer and infectious diseases which can help in early detection of the disease. Hyperenzymospermia in patients with RS...